Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Kimberly-Clark Corporation (KMB) Stock Forecast & Price Prediction United States | NYSE | Consumer Defensive | Household & Personal Products
$143.84
+1.16 (0.81%)Did KMB Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Kimberly-Clark is one of their latest high-conviction picks.
Based on our analysis of 26 Wall Street analysts, KMB has a neutral consensus with a median price target of $143.23 (ranging from $118.00 to $162.00). The overall analyst rating is Buy (6.6/10). Currently trading at $143.84, the median forecast implies a -0.4% downside. This outlook is supported by 6 Buy, 12 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Nik Modi at RBC Capital, projecting a 12.6% upside. Conversely, the most conservative target is provided by Filippo Falorni at Citigroup, suggesting a 18.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for KMB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 24, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $135.00 |
| Apr 23, 2025 | RBC Capital | Nik Modi | Outperform | Maintains | $162.00 |
| Apr 23, 2025 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $156.00 |
| Apr 23, 2025 | Evercore ISI Group | Javier Escalante | Outperform | Maintains | $155.00 |
| Apr 17, 2025 | UBS | Peter Grom | Neutral | Maintains | $146.00 |
| Apr 17, 2025 | RBC Capital | Nik Modi | Outperform | Reiterates | $165.00 |
| Apr 11, 2025 | JP Morgan | Andrea Teixeira | Underweight | Maintains | $131.00 |
| Mar 28, 2025 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $140.00 |
| Mar 27, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $144.00 |
| Jan 29, 2025 | Piper Sandler | Korinne Wolfmeyer | Overweight | Reiterates | $158.00 |
| Jan 29, 2025 | UBS | Peter Grom | Neutral | Maintains | $134.00 |
| Jan 24, 2025 | RBC Capital | Nik Modi | Outperform | Reiterates | $165.00 |
| Jan 17, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $132.00 |
| Jan 16, 2025 | JP Morgan | Andrea Teixeira | Underweight | Maintains | $124.00 |
| Jan 16, 2025 | UBS | Peter Grom | Neutral | Maintains | $132.00 |
| Jan 15, 2025 | Citigroup | Filippo Falorni | Sell | Maintains | $118.00 |
| Jan 8, 2025 | TD Cowen | Robert Moskow | Hold | Downgrade | $145.00 |
| Jan 7, 2025 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $130.00 |
| Jan 6, 2025 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $161.00 |
| Oct 23, 2024 | UBS | Peter Grom | Neutral | Maintains | $151.00 |
The following stocks are similar to Kimberly-Clark based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Kimberly-Clark Corporation has a market capitalization of $47.73B with a P/E ratio of 19.6x. The company generates $19.75B in trailing twelve-month revenue with a 12.5% profit margin.
Revenue growth is -6.0% quarter-over-quarter, while maintaining an operating margin of +16.9% and return on equity of +207.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces essential consumer goods and healthcare products.
Kimberly-Clark generates revenue through the sale of a diverse range of consumer goods, including personal care items like diapers and feminine products, as well as paper products such as tissues and towels. The company leverages a global distribution network to reach consumers and businesses, ensuring a strong market presence across various sectors, including retail and healthcare.
Founded in 1872, Kimberly-Clark is known for its commitment to sustainability and responsible supply chain management. The company continually innovates to adapt to changing consumer needs while aiming to maintain its leadership in the industry and contribute positively to environmental and social outcomes.
Consumer Defensive
Household & Personal Products
38,000
Mr. Michael D. Hsu
United States
1984
KMB's 'Powering Care' drives steady growth, with strong volume gains, disciplined costs and portfolio shifts boosting profits despite pricing pressure.
Kimberly-Clark can sustain its dividend through operations despite lower earnings and plans to finalize its Kenvue acquisition later this year.
Kimberly-Clark's ability to sustain its dividend amid declining earnings signals financial stability, while the Kenvue acquisition may enhance future growth potential.
Costco and Walmart are seen as valuable to customers but may not attract new investors. Kimberly-Clark's strategic changes could yield long-term benefits.
Costco and Walmart's value perception may deter new investment, while Kimberly-Clark's strategic shift suggests potential for future growth, influencing portfolio decisions.
Kimberly-Clark is adopting a lean regional structure to enhance efficiency as it prepares for the $48.7B acquisition of Kenvue, expected to close in the second half of 2026.
Kimberly-Clark's streamlined structure aims to enhance efficiency ahead of the Kenvue acquisition, signaling potential growth and value creation opportunities for shareholders.
Kimberly-Clark's CFO, Nelson Urdaneta, will lead finance for the new entity formed after its $40 billion acquisition of Kenvue, the maker of Tylenol.
Urdaneta's appointment signals continuity in financial leadership, which can stabilize investor confidence amid the $40 billion acquisition, impacting stock performance and future growth prospects.
The new combined company will feature consumer brands like Kleenex and Huggies, along with over-the-counter products like Tylenol and Listerine, organized into four geographic segments.
The merger creates a stronger portfolio of well-known brands, potentially enhancing market share and revenue, which can positively impact stock performance and investor confidence.
Kimberly-Clark Corporation announced its new organizational structure and leadership to take effect after its acquisition of Kenvue Inc., aligning with its ongoing Powering Care strategy.
Kimberly-Clark's restructuring and leadership changes post-acquisition signal a strategic shift, potentially enhancing operational efficiency and growth, impacting future profitability and stock performance.
Based on our analysis of 26 Wall Street analysts, Kimberly-Clark Corporation (KMB) has a median price target of $143.23. The highest price target is $162.00 and the lowest is $118.00.
According to current analyst ratings, KMB has 6 Buy ratings, 12 Hold ratings, and 2 Sell ratings. The stock is currently trading at $143.84. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict KMB stock could reach $143.23 in the next 12 months. This represents a -0.4% decrease from the current price of $143.84. Please note that this is a projection by Wall Street analysts and not a guarantee.
Kimberly-Clark generates revenue through the sale of a diverse range of consumer goods, including personal care items like diapers and feminine products, as well as paper products such as tissues and towels. The company leverages a global distribution network to reach consumers and businesses, ensuring a strong market presence across various sectors, including retail and healthcare.
The highest price target for KMB is $162.00 from Nik Modi at RBC Capital, which represents a 12.6% increase from the current price of $143.84.
The lowest price target for KMB is $118.00 from Filippo Falorni at Citigroup, which represents a -18.0% decrease from the current price of $143.84.
The overall analyst consensus for KMB is neutral. Out of 26 Wall Street analysts, 6 rate it as Buy, 12 as Hold, and 2 as Sell, with a median price target of $143.23.
Stock price projections, including those for Kimberly-Clark Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.